|
1
|
Heiden MG Vander, Lunt SY, Dayton TL,
Fiske BP, Israelsen WJ, Mattaini KR, Vokes NI, Stephanopoulos G,
Cantley LC, Metallo CM, et al: Metabolic pathway alterations that
support cell proliferation. Cold Spring Harb Symp Quant Biol.
76:325–334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Christensen DR, Calder PC and Houghton FD:
GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic
culture of human embryonic stem cells. Sci Rep. 5:175002015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iqbal MA, Gupta V, Gopinath P, Mazurek S
and Bamezai RN: Pyruvate kinase M2 and cancer: An updated
assessment. FEBS Lett. 588:2685–2692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamada M, Suematsu M and Saya H: Pyruvate
kinase M2: Multiple faces for conferring benefits on cancer cells.
Clin Cancer Res. 18:5554–5561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo W and Semenza GL: Emerging roles of
PKM2 in cell metabolism and cancer progression. Trends Endocrinol
Metab. 23:560–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang Y, Li X, Yang W, Hawke DH, Zheng Y,
Xia Y, Aldape K, Wei C, Guo F, Chen Y, et al: PKM2 regulates
chromosome segregation and mitosis progression of tumor cells. Mol
Cell. 53:75–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Yang P and Li Z: The multifaceted
regulation and functions of PKM2 in tumor progression. Biochim
Biophys Acta. 1846:285–296. 2014.PubMed/NCBI
|
|
8
|
Li SL, Ye F, Cai WJ, Hu HD, Hu P, Ren H,
Zhu FF and Zhang DZ: Quantitative proteome analysis of multidrug
resistance in human ovarian cancer cell line. J Cell Biochem.
109:625–633. 2010.PubMed/NCBI
|
|
9
|
Wang Y, Zhang X, Zhang Y, Zhu Y, Yuan C,
Qi B, Zhang W, Wang D, Ding X, Wu H, et al: Overexpression of
pyruvate kinase M2 associates with aggressive clinicopathological
features and unfavorable prognosis in oral squamous cell carcinoma.
Cancer Biol Ther. 16:839–845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valent P, Bonnet D, Wöhrer S, Andreeff M,
Copland M, Chomienne C and Eaves C: Heterogeneity of neoplastic
stem cells: Theoretical, functional, and clinical implications.
Cancer Res. 73:1037–1045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Islam F, Gopalan V, Smith RA and Lam AK:
Translational potential of cancer stem cells: A review of the
detection of cancer stem cells and their roles in cancer recurrence
and cancer treatment. Exp Cell Res. 335:135–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tomasetti C and Vogelstein B: Cancer
etiology. Variation in cancer risk among tissues can be explained
by the number of stem cell divisions. Science. 347:78–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Visvader JE: Cells of origin in cancer.
Nature. 469:314–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Woodward WA and Sulman EP: Cancer stem
cells: Markers or biomarkers? Cancer Metastasis Rev. 27:459–470.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Y and Wu PY: CD133 as a marker for
cancer stem cells: Progresses and concerns. Stem Cells Dev.
18:1127–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suda T, Takubo K and Semenza GL: Metabolic
regulation of hematopoietic stem cells in the hypoxic niche. Cell
Stem Cell. 9:298–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bertolini G, Roz L, Perego P, Tortoreto M,
Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S,
et al: Highly tumorigenic lung cancer CD133+ cells
display stem-like features and are spared by cisplatin treatment.
Proc Natl Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tamada M, Nagano O, Tateyama S, Ohmura M,
Yae T, Ishimoto T, Sugihara E, Onishi N, Yamamoto T, Yanagawa H, et
al: Modulation of glucose metabolism by CD44 contributes to
antioxidant status and drug resistance in cancer cells. Cancer Res.
72:1438–1448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo CY, Luo L, Urata Y, Goto S, Huang WJ,
Takamura S, Hayashi F, Doi H, Kitajima Y, Ono Y, et al: Sensitivity
and dose dependency of radiation-induced injury in hematopoietic
stem/progenitor cells in mice. Sci Rep. 5:80552015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li TS, Cheng K, Lee ST, Matsushita S,
Davis D, Malliaras K, Zhang Y, Matsushita N, Smith RR and Marbán E:
Cardiospheres recapitulate a niche-like microenvironment rich in
stemness and cell-matrix interactions, rationalizing their enhanced
functional potency for myocardial repair. Stem Cells. 28:2088–2098.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan C, Luo L, Goto S, Urata Y, Guo CY, Doi
H, Kitazato K and Li TS: Enhanced autophagy in colorectal cancer
stem cells does not contribute to radio-resistance. Oncotarget.
7:45112–45121. 2016.PubMed/NCBI
|
|
25
|
Christofk HR, Heiden MG Vander, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Israelsen WJ, Dayton TL, Davidson SM,
Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW,
et al: PKM2 isoform-specific deletion reveals a differential
requirement for pyruvate kinase in tumor cells. Cell. 155:397–409.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cortés-Cros M, Hemmerlin C, Ferretti S,
Zhang J, Gounarides JS, Yin H, Muller A, Haberkorn A, Chene P,
Sellers WR, et al: M2 isoform of pyruvate kinase is dispensable for
tumor maintenance and growth. Proc Natl Acad Sci USA. 110:489–494.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dombrauckas JD, Santarsiero BD and Mesecar
AD: Structural basis for tumor pyruvate kinase M2 allosteric
regulation and catalysis. Biochemistry. 44:9417–9429. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishimoto T, Nagano O, Yae T, Tamada M,
Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, et al:
CD44 variant regulates redox status in cancer cells by stabilizing
the xCT subunit of system xc(−) and thereby promotes tumor growth.
Cancer Cell. 19:387–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Papadaki C, Sfakianaki M, Lagoudaki E,
Giagkas G, Ioannidis G, Trypaki M, Tsakalaki E, Voutsina A,
Koutsopoulos A, Mavroudis D, et al: PKM2 as a biomarker for
chemosensitivity to front-line platinum-based chemotherapy in
patients with metastatic non-small-cell lung cancer. Br J Cancer.
111:1757–1764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamabe A, Konno M, Tanuma N, Shima H,
Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, et
al: Role of pyruvate kinase M2 in transcriptional regulation
leading to epithelial-mesenchymal transition. Proc Natl Acad Sci
USA. 111:15526–15531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo
F, Lyssiotis CA, Aldape K, Cantley LC and Lu Z: ERK1/2-dependent
phosphorylation and nuclear translocation of PKM2 promotes the
Warburg effect. Nat Cell Biol. 14:1295–1304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Benoit YD, Guezguez B, Boyd AL and Bhatia
M: Molecular pathways: Epigenetic modulation of Wnt-glycogen
synthase kinase-3 signaling to target human cancer stem cells. Clin
Cancer Res. 20:5372–5378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chappell J and Dalton S: Roles for MYC in
the establishment and maintenance of pluripotency. Cold Spring Harb
Perspect Med. 3:a0143812013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
